MLV & Co. Upgrades BioCryst Pharma (BCRX) to Buy
Tweet
Share
E-mailGet Alerts BCRX Hot Sheet
Price: $4.16 -1.19%
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
MLV & Co. upgraded BioCryst Pharma (NASDAQ: BCRX) from Hold to Buy.
For an analyst ratings summary and ratings history on BioCryst Pharma click here. For more ratings news on BioCryst Pharma click here.
Shares of BioCryst Pharma closed at $1.92 yesterday.
For an analyst ratings summary and ratings history on BioCryst Pharma click here. For more ratings news on BioCryst Pharma click here.
Shares of BioCryst Pharma closed at $1.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades UPS (UPS) to Buy, 'Back to earnings growth'
- BofA Securities Upgrades Tesla (TSLA) to Buy on wind up of positive catalysts
- Deutsche Bank Upgrades Acadia Healthcare (ACHC) to Hold 'on a neutral risk/ reward'
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
